RT Journal Article
SR Electronic
T1 Strong Effect of Demographic Changes on Tuberculosis Susceptibility in South Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.02.23297990
DO 10.1101/2023.11.02.23297990
A1 Oyageshio, Oshiomah P.
A1 Myrick, Justin W.
A1 Saayman, Jamie
A1 van der Westhuizen, Lena
A1 Al-Hindi, Dana
A1 Reynolds, Austin W.
A1 Zaitlen, Noah
A1 Uren, Caitlin
A1 Möller, Marlo
A1 Henn, Brenna M.
YR 2023
UL http://medrxiv.org/content/early/2023/11/04/2023.11.02.23297990.abstract
AB South Africa is among the world’s top eight TB burden countries, and despite a focus on HIV-TB co-infection, most of the population living with TB are not HIV co-infected. The disease is endemic across the country with 80-90% exposure by adulthood. We investigated epidemiological risk factors for tuberculosis (TB) in the Northern Cape Province, South Africa: an understudied TB endemic region with extreme TB incidence (645/100,000) and the lowest provincial population density. We leveraged the population’s high TB incidence and community transmission to design a case-control study with population-based controls, reflecting similar mechanisms of exposure between the groups. We recruited 1,126 participants with suspected TB from 12 community health clinics, and generated a cohort of 878 individuals (cases =374, controls =504) after implementing our enrollment criteria. All participants were GeneXpert Ultra tested for active TB by a local clinic. We assessed important risk factors for active TB using logistic regression and random forest modeling. Additionally, a subset of individuals were genotyped to determine genome-wide ancestry components. Male gender had the strongest effect on TB risk (OR: 2.87 [95% CI: 2.1-3.8]); smoking and alcohol consumption did not significantly increase TB risk. We identified two interactions: age by socioeconomic status (SES) and birthplace by residence locality on TB risk (OR = 3.05, p = 0.016) – where rural birthplace but town residence was the highest risk category. Finally, participants had a majority Khoe-San ancestry, typically greater than 50%. Epidemiological risk factors for this cohort differ from other global populations. The significant interaction effects reflect rapid changes in SES and mobility over recent generations and strongly impact TB risk in the Northern Cape of South Africa. Our models show that such risk factors combined explain 16% of the variance (r2) in case/control status.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by NIH grant R35GM133531 to BMH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The South African government also partially funded this research through the South African Medical Research Council and the National Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been approved by the Health Research Ethics Committee (HREC) of Stellenbosch University (N11/07/210A), and the Northern Cape Department of Health (NC2015/008).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll R scripts for statistical data analyses and data visualization are available at https://github.com/oshiomah1/NCTB-Epidemiology-Project. The relevant raw data will be deposited in EGA database. https://github.com/oshiomah1/NCTB-Epidemiology-Project/tree/main